文献速递流行病学与生物统计

世界卫生组织关于冲突环境下精神障碍患病率的新估计:系统综述与Meta分析

New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis.
PubMed 文献 · Lancet · 2019-06-12

该研究更新了世界卫生组织关于冲突影响人群中精神障碍患病率的估计,检索2000年1月1日至2017年8月9日发表的研究,采用贝叶斯Meta回归计算患病率。结果显示,任何精神障碍的时点患病率为22.1%(95%不确定性区间18.8-25.7),轻度抑郁、焦虑和创伤后应激障碍为13.0%(95%不确定性区间10.3-16.2),中度形式为4.0%(95%不确定性区间2.9-5.5),严重障碍为5.1%(95%不确定性区间4.0-6.5)。

要点

  • 冲突影响人群中任何精神障碍的时点患病率为22.1%(95%不确定性区间18.8-25.7)。
  • 轻度抑郁、焦虑和创伤后应激障碍的年龄标准化时点患病率为13.0%(95%不确定性区间10.3-16.2)。
  • 严重障碍(精神分裂症、双相障碍、重度抑郁、重度焦虑和重度创伤后应激障碍)的患病率为5.1%(95%不确定性区间4.0-6.5)。

核心结论

  • 冲突影响人群中精神障碍负担高,迫切需要实施可扩展的精神卫生干预措施以应对这一负担。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE(PubMed)、PsycINFO和Embase中2000年1月1日至2017年8月9日发表的关于抑郁、焦虑障碍、创伤后应激障碍、双相障碍和精神分裂症患病率的研究,并检索灰色文献及现有综述的数据集和参考文献列表。
  • 采用《准确透明健康估计报告指南》和贝叶斯Meta回归技术,对过去10年内经历过冲突的环境中精神障碍的预测因素进行调整,计算新的时点患病率估计及95%不确定性区间。

主要发现

  • 所评估的冲突影响人群中,任何时点精神障碍(抑郁、焦虑、创伤后应激障碍、双相障碍和精神分裂症)的患病率为22.1%(95%不确定性区间18.8-25.7)。
  • 经共病调整和年龄标准化的平均时点患病率:轻度抑郁、焦虑和创伤后应激障碍为13.0%(95%不确定性区间10.3-16.2),中度形式为4.0%(95%不确定性区间2.9-5.5)。
  • 严重障碍(精神分裂症、双相障碍、重度抑郁、重度焦虑和重度创伤后应激障碍)的经共病调整和年龄标准化的平均时点患病率为5.1%(95%不确定性区间4.0-6.5)。
  • 由于仅有两项研究提供了冲突影响人群中精神病的流行病学数据,这些估计中使用了现有的全球疾病负担研究中精神分裂症和双相障碍的估计值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 由于仅有两项研究提供了冲突影响人群中精神病的流行病学数据,这些估计中使用了现有的全球疾病负担研究中精神分裂症和双相障碍的估计值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Existing WHO estimates of the prevalence of mental disorders in emergency settings are more than a decade old and do not reflect modern methods to gather existing data and derive estimates. We sought to update WHO estimates for the prevalence of mental disorders in conflict-affected settings and calculate the burden per 1000 population. METHODS: In this systematic review and meta-analysis, we updated a previous systematic review by searching MEDLINE (PubMed), PsycINFO, and Embase for studies published between Jan 1, 2000, and Aug 9, 2017, on the prevalence of depression, anxiety disorder, post-traumatic stress disorder, bipolar disorder, and schizophrenia. We also searched the grey literature, such as government reports, conference proceedings, and dissertations, to source additional data, and we searched datasets from existing literature reviews of the global prevalence of depression and anxiety and reference lists from the studies that were identified. We applied the Guidelines for Accurate and Transparent Health Estimates Reporting and used Bayesian meta-regression techniques that adjust for predictors of mental disorders to calculate new point prevalence estimates with 95% uncertainty intervals (UIs) in settings that had experienced conflict less than 10 years previously. FINDINGS: We estimated that the prevalence of mental disorders (depression, anxiety, post-traumatic stress disorder, bipolar disorder, and schizophrenia) was 22·1% (95% UI 18·8-25·7) at any point in time in the conflict-affected populations assessed. The mean comorbidity-adjusted, age-standardised point prevalence was 13·0% (95% UI 10·3-16·2) for mild forms of depression, anxiety, and post-traumatic stress disorder and 4·0% (95% UI 2·9-5·5) for moderate forms. The mean comorbidity-adjusted, age-standardised point prevalence for severe disorders (schizophrenia, bipolar disorder, severe depression, severe anxiety, and severe post-traumatic stress disorder) was 5·1% (95% UI 4·0-6·5). As only two studies provided epidemiological data for psychosis in conflict-affected populations, existing Global Burden of Disease Study estimates for schizophrenia and bipolar disorder were applied in these estimates for conflict-affected populations. INTERPRETATION: The burden of mental disorders is high in conflict-affected populations. Given the large numbers of people in need and the humanitarian imperative to reduce suffering, there is an urgent need to implement scalable mental health interventions to address this burden. FUNDING: WHO; Queensland Department of Health, Australia; and Bill & Melinda Gates Foundation.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Charlson F, van Ommeren M, Flaxman A, et al. New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis. Lancet. 2019. PMID: 31200992. doi:10.1016/S0140-6736(19)30934-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。